DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Tata Chemicals Limited — Bagging/Receiving of orders/contracts (Sub-para 4-Para B)

NSE 2d ago·28 Aug 2026, 7:23 pm

Tata Chemicals

Tata Chemicals has informed the stock exchanges that it has received new orders or contracts. The company did not disclose the specific value or nature of these deals in the regulatory filing.

This news is significant for investors as it indicates business expansion and potential revenue growth. It suggests the company is actively securing new business, which can positively impact its future financial performance and market valuation.

Investors should watch for the company's upcoming quarterly results to see if these new orders translate into actual sales. Monitoring the company's future announcements for more details on these contracts will also be important.